Professor, Proctor Foundation, UCSF School of Medicine
Ophthalmology
Dr. Thomas M. Lietman, MD
|
|
Give Review
Thomas Lietman practices Ophthalmology. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He over the years received 1 awards: "Fellow (FAAO)". Dr. Thomas M. Lietman has written publications. He has 101 publications published with PubMed. The lastest publication is: 'Association of Biofilm Formation, Psl Exopolysaccharide Expression, and Clinical Outcomes in Pseudomonas aeruginosa Keratitis: Analysis of Isolates in the Steroids for...'
Publications
- Association of Biofilm Formation, Psl Exopolysaccharide Expression, and Clinical Outcomes in Pseudomonas aeruginosa Keratitis: Analysis of Isolates in the Steroids for...
- Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
- The Effect of Mass Azithromycin Distribution on Childhood Mortality: Beliefs and Estimates of Efficacy.
- Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
- The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining.
- Antibiotic resistance as collateral damage: The tragedy of the commons in a two-Disease setting.
- Evidence for clonal expansion after antibiotic selection pressure: pneumococcal multilocus sequence types before and after mass azithromycin treatments.
- Optimal Seasonal Timing of Oral Azithromycin for Malaria.
- Does mass azithromycin distribution impact child growth and nutrition in niger? A cluster-randomized trial.
- Importance of Including Borderline Cases in Trachoma Grader Certification.
- Reliability of trachoma clinical grading-assessing grading of marginal cases.
- Estimating Community Prevalence of Ocular Chlamydia trachomatis Infection using Pooled Polymerase Chain Reaction Testing.
- Early Addition of Topical Corticosteroids in the Treatment of Bacterial Keratitis.
- Association between In Vitro Susceptibility to Natamycin and Voriconazole and Clinical Outcomes in Fungal Keratitis.
- Visual outcomes in treated bacterial Keratitis: four years of prospective follow-up.
- Challenges of Ophthalmic Care in the Developing World.
- Visual Recovery in Treated Bacterial Keratitis.
- The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial.
- Impact of Mass Azithromycin Distribution on Malaria Parasitemia during the Low-Transmission Season in Niger: A Cluster-Randomized Trial.
- Follicle size in trachoma: assessment of a well-known trachoma grading diagram.
- The steroids for Corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
- In vitro susceptibility of filamentous fungal isolates from a Corneal ulcer clinical trial.
- Evaluation of Fungal Keratitis using a Newly Developed Computer Program, Optscore, for Grading Digital Corneal Photographs.
- Acanthamoeba, fungal, and bacterial Keratitis: a comparison of risk factors and clinical features.
- The Association between Latrine Use and Trachoma: A Secondary Cohort Analysis from a Randomized Clinical Trial.
- Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity.
- Emerging Moxifloxacin Resistance in Pseudomonas aeruginosa Keratitis Isolates in South India.
- Expert Prior Elicitation and Bayesian Analysis of the Mycotic Ulcer Treatment Trial I.
- Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial Keratitis.
- The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger.
- Improvement in Corneal scarring following bacterial keratitis.
- When Does Overuse of Antibiotics Become a Tragedy of the Commons?
- A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger.
- Predictors of Matching in an Ophthalmology Residency Program.
- Prior elicitation and bayesian analysis of the steroids for Corneal ulcers trial.
- Seasonal Trends of Microbial Keratitis in South India.
- Application of smartphone cameras for detecting clinically active trachoma.
- Trachoma: an update on prevention, diagnosis, and treatment.
- Gender and conjunctival bacterial infection in cicatricial trachoma.
- The clinical differentiation of bacterial and fungal Keratitis: a photographic survey.
- Pseudomonas aeruginosa Keratitis: Outcomes and Response to Corticosteroid Treatment.
- Diagnostic test characteristics of tests for ocular chlamydia after mass azithromycin distributions.
- Ribosomal RNA Evidence of Ocular Chlamydia trachomatis Infection Following 3 Annual Mass Azithromycin Distributions in Communities With Highly Prevalent Trachoma.
- Practice Patterns and Opinions in the Treatment of Acanthamoeba Keratitis.
- Gender differences in re-epithelialisation time in fungal Corneal ulcers.
- Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.
- Adverse events after mass azithromycin treatments for trachoma in ethiopia.
- How reliable are tests for trachoma? A latent class approach.
- Pre-existing blindness in a cohort of patients with bacterial Keratitis.
- Natamycin and voriconazole in fungal Keratitis--reply.
- Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.
- Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.
- Slow resolution of clinically active trachoma following successful mass antibiotic treatments.
- Childhood mortality in a cohort treated with mass azithromycin for trachoma.
- The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.
- Comparison of natamycin and voriconazole for the treatment of fungal Keratitis.
- Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
- Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial.
- Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
- Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
- The steroid controversy in bacterial Keratitis.
- Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.
- When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
- Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
- Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.
- Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
- Prospective comparison of microbial culture and polymerase chain reaction in the diagnosis of Corneal ulcer.
- ASCRS survey of endophthalmitis prophylaxis.
- Does in vitro susceptibility predict clinical outcome in bacterial Keratitis?
- Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
- Complete elimination is a difficult goal for trachoma programs in severely affected communities.
- Reports on the prevalence of clinical conditions are more convincing when supported by objective evidence.
- Parasites on the rise: a new epidemic of Acanthamoeba Keratitis.
- Spectrum of eye Disease caused by methicillin-resistant Staphylococcus aureus.
- The return of trachoma in partially treated communities.
- Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from Keratitis.
- Chlamydia on children and flies after mass antibiotic treatment for trachoma.
- Atopic Disease and herpes simplex eye Disease: a population-based case-control study.
- Outbreak of Fusarium Keratitis in soft contact lens wearers in San Francisco.
- Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries.
- Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
- Seasonal effects in the elimination of trachoma.
- Mass antibiotics for trachoma and the Allee effect.
- Single-dose azithromycin for trachoma.
- Mass antibiotic treatment and community protection in trachoma control programs.
- Trachoma decline and widespread use of antimicrobial drugs.
- Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
- Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?
- Efficacy of transport media use versus direct inoculation of blood agar plates in the microbiologic evaluation of experimental Streptococcus pneumoniae Keratitis.
- Clinical signs in dematiaceous and hyaline fungal Keratitis.
- Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population.
- Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
- The epidemiological dynamics of infectious trachoma may facilitate elimination.
- Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from Keratitis.
- Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.
- Susceptibility testing and clinical outcome in fungal Keratitis.
- Travel and implications for the elimination of trachoma in ethiopia.
- A rationale for continuing mass antibiotic distributions for trachoma.
- Effect of statin drugs and aspirin on progression in open-angle Glaucoma suspects using confocal scanning laser ophthalmoscopy.
- Targeted treatment of active trachoma.
Schools
Columbia University College of Physicians And Surgeons
Union Meml
Wilmer Eye Institute Johns Hopkins University
Proctor Found Uc San Francisco
Procedures Preformed
- Cataract Removal Surgery
Conditions Treated
- Age-Related Macular Degeneration
- Astigmatism
- Behçet's Disease
- Blepharitis
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Basic Exclusive PPO for Small Business
- Brown & Toland Physicians
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- WholeCare Network HMO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- Fellow (FAAO)
Education
-
Johns Hopkins University -
Columbia University College of Physicians & Surgeons
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Wayne E. Fung, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred L. Dobrow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nisha R. Acharya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan C. Horton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John McNamara, DO |
|
|
Dr. Kenneth C. Ip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig H. Kliger, MD |
|
|
Dr. Ako Takakura, MD |